Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Hires Key Personnel, Plans to Expand Lab Staff for R&D in 2019 and Issues Stock Options
LXRP is putting its growth plan into effect, adding a new corporate controller, a head of its legal division and more office staff; in 2019, it will also be increasing its lab personnel As a result of the latest positions created, the company is issuing 240,000 new stock options with an exercise price of $1.06 that will vest as to 80,000 per year until April 15, 2021 LXRP has a growing IP portfolio of 10 patents granted in the U.S. and Australia; it has filed for more than 50 patents worldwide across 10 patent families Lexaria Bioscience Corp. (CSE: LXX)…

















